Back to results
US 2026/0066047 A1Published application
Models and methods for predicting cell-surface protein expression
AssigneeWisconsin Alumni Research Foundation
InventorShuang Zhao
Life of this patent
Estimating the term…
Abstract
Models and methods for predicting cell-surface protein expression, such as expression of cell-surface targets on cancer cells.
Claims20
A method of generating a prediction model of cell-surface protein expression in cancer, the method comprising:
- determining a gene expression profile for each training cell sample in a set of training cell samples, wherein each gene expression profile comprises a set of gene-expression values for a set of gene-expression-profile genes, wherein the set of training cell samples comprises a set of training cancer cell samples;
- determining a set of training genes, wherein the set of training genes comprises a common set of gene-expression-profile genes represented in each of the gene expression profiles, wherein the set of training genes comprises a set of cell-surface protein genes;
- ranking the gene-expression values for all of the training genes in each expression profile to thereby obtain a training ranking for each gene expression profile, wherein each training ranking comprises a rank for the gene-expression value for each training gene within the gene expression profile;
- identifying, for each training gene, the training cell samples having a same rank.
1 more element
A method of using a prediction model to determine a predicted cell-surface target on a patient cancer cell sample, the method comprising:
- ranking gene-expression values of all of a plurality of training genes in the patient cancer cell sample to obtain a patient ranking;
- selecting one or more training genes having a threshold rank in the patient ranking to thereby obtain one or more patient genes;
- comparing the rank(s) of the one or more patient genes in the patient cancer cell sample with the rank(s) of the one or more patient genes in the training cell samples to determine a number, type, and/or proportion of training cancer cell samples having the same rank(s) for the one or more patient genes;
- and
- optionally, empirically testing cell-surface expression of the one or more patient genes in a test cancer cell sample from the patient.
2 more elements
Dependencies are inferred from the claim text.